Albert L. Siu, MD, MSPH; Kirsten Bibbins-Domingo, PhD, MD, MAS; David C. Grossman, MD, MPH; Michael L. LeFevre, MD, MSPH; on behalf of the U.S. Preventive Services Task Force *
Note: The U.S. Preventive Services Task (USPSTF) is an independent expert panel that reviews the scientific evidence for preventive services and makes recommendations based on this evidence for patients and health care providers.
Disclaimer: The views expressed in this editorial are those of the USPSTF. USPSTF members are independent of the U.S. government. The views expressed in this editorial should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Financial Support: The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-3065.
Siu AL, Bibbins-Domingo K, Grossman DC, et al, on behalf of the U.S. Preventive Services Task Force. Convergence and Divergence Around Breast Cancer Screening. Ann Intern Med. 2016;164:301–302. [Epub ahead of print 12 January 2016]. doi: https://doi.org/10.7326/M15-3065
Download citation file:
Published: Ann Intern Med. 2016;164(4):301-302.
Published at www.annals.org on 12 January 2016
Breast Cancer, Cancer Screening/Prevention, Hematology/Oncology, Prevention/Screening.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use